Strategic Partnerships Elpis Biopharmaceuticals is actively pursuing collaborations with major cancer centers in Singapore (National Cancer Centre Singapore) and SGH, presenting opportunities to position your organization as a collaborative research partner or supplier for translational cell therapy programs and joint translational studies.

Clinical-Stage Collaboration As a clinical-stage company focused on bispecific armored CAR-T therapies for solid tumors, there is a market opening to offer contract research, translational studies, manufacturing development support, and early-access drug development services to accelerate their preclinical-to-clinical transitions.

Biologics & Cell Therapy Their emphasis on cellular and biologic therapeutics signals potential demand for GMP manufacturing, Vector/CAR-T production, quality assurance, and regulatory consulting to scale experimental therapies toward clinical trials.

Engagement & Thought Leadership Participation in prominent industry events (PEGS Summit, AACR-like forums) and active data presentation indicate openness to strategic sponsorships, speaker placements, and joint webinars to raise visibility and attract co-development or funding partners.

Resource & Capabilities Fit With a lean team (11-50 employees) and reported revenue in the low to mid millions, there is opportunities to offer scalable outsourcing services (analytical development, process development, bioprocess optimization, and program management) to support their growth without full-time internal expansion.